Our results suggest that the modulation of the p53-miR-18-HSF2-IGF-IIR pathway in the heart is essential for cardiomyocyte morphology and cardiac function, which profoundly influence cardiac hypertrophy during hypertension-induced heart failure. Here, TP53 is linked to cardiac hypertrophy.